Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Cash from Investing Activities (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Cash from Investing Activities for 6 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 57.58% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.4 million, a 112.2% decrease, with the full-year FY2025 number at -$9.4 million, down 112.2% from a year prior.
  • Cash from Investing Activities was -$1.8 million for Q4 2025 at PROCEPT BioRobotics, up from -$2.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$39000.0 in Q1 2021 to a low of -$8.7 million in Q4 2023.
  • A 5-year average of -$2.1 million and a median of -$1.3 million in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: crashed 9607.27% in 2023, then skyrocketed 95.74% in 2024.
  • PROCEPT BioRobotics' Cash from Investing Activities stood at -$332000.0 in 2021, then tumbled by 160.84% to -$866000.0 in 2022, then plummeted by 906.35% to -$8.7 million in 2023, then surged by 86.53% to -$1.2 million in 2024, then tumbled by 57.58% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Cash from Investing Activities are -$1.8 million (Q4 2025), -$2.9 million (Q3 2025), and -$2.8 million (Q2 2025).